Influenza News and Research

Latest Influenza News and Research

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Inovio Pharmaceuticals, Inc. announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge.

27 May 2014

Employers to implement mandatory influenza vaccination policies for health care workers

Employers planning to implement mandatory influenza vaccination policies for health care workers need to understand the implications, according to an analysis published in CMAJ (Canadian Medical Association Journal).

27 May 2014

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Inovio Pharmaceuticals, Inc. today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock.

23 May 2014

Despite worsening economic conditions, infant health improves among poor Americans

Despite worsening economic conditions for those at the bottom, infant health has steadily improved among the most disadvantaged Americans, according to a review published in Science by Princeton University's Woodrow Wilson School of Public and International Affairs

23 May 2014

School-based influenza vaccine programs limited by low rates of reimbursement

School-based influenza vaccine programs have the potential to reach many children at affordable costs and with parental support, but these programs are limited by low rates of reimbursement from third-party payers, according to recently published study results by researchers from the University of Colorado School of Medicine.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Current smoking heralds worse outcomes in pneumococcal CAP

Hospital patients with pneumococcal community-acquired pneumonia have worse outcomes if they are current smokers than if they are non- or ex-smokers, results of a large observational study suggest.

19 May 2014

Registration now open for interactive one day workshop for GPs

Registration is now open for an interactive one day workshop in Brisbane, designed by GPs for GPs, that will cover five hot topics — including statin prescribing and whether the hype is justified on newer oral anticoagulants.

19 May 2014

Viewpoints: GOP attacks on health law; challenging assumptions about Obamacare politics; is employer mandate worth it?

A crucial component of the Republican Party's assault on the Affordable Care Act always has been ignorance -- that is, the promotion of ignorance about the ACA's benefits among the general population. Now, from the consulting firm McKinsey & Co., comes hard evidence that the campaign worked, bigtime. In its latest national survey to determine how the healthcare reform act has been working, McKinsey found that the perceived cost of health insurance still was the No. 1 reason given by respondents for not enrolling (Michael Hiltzik, 5/14).

16 May 2014

Findings from 1918 Flu Pandemic research could help improve current health policies

The 1918 Flu Pandemic infected over 500 million people, killing at least 50 million. Now, a researcher at the University of Missouri has analyzed the pandemic in two remote regions of North America, finding that despite their geographical divide, both regions had environmental, nutritional and economic factors that influenced morbidity during the pandemic.

15 May 2014

ACP, CECity and Pfizer announce new initiative designed to increase adult immunization rates

The American College of Physicians (ACP), CECity, and Pfizer Inc. (NYSE:PFE) today announced a new initiative designed to increase adult immunization rates by assisting physicians and other health care providers in strongly recommending appropriate vaccination and tracking adult immunization rates for quality measurement and improvement.

15 May 2014

DaVita wins 2014 Immunization Excellence Awards in "Healthcare Personnel Campaign" category

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, was recognized at the National Adult and Influenza Immunization Summit (NAIIS) as the national winner in the "Healthcare Personnel Campaign" category of the 2014 Immunization Excellence Awards.

14 May 2014

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.

12 May 2014

Researchers create universal flu vaccine

Researchers at the University of Texas Medical Branch are working to create a universal flu vaccine - one that could eliminate the need for an annual flu shot.

8 May 2014

MinuteClinic walk-in medical clinics open in central Georgia

The first MinuteClinic walk-in medical clinics in central Georgia have opened inside two CVS/pharmacy stores in Macon and one in Warner Robbins.

7 May 2014

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Lipids, primarily cholesterol and triglycerides, come from two sources: what is naturally manufactured in the liver and what comes from the intestines through the diet.

From Sanofi 7 May 2014

Johns Hopkins researchers awarded NIH contract to launch new center to track influenza viruses

The National Institutes of Health has awarded a contract to researchers at The Johns Hopkins University to launch a new center devoted to developing innovative ways to identify and track influenza viruses worldwide.

6 May 2014

Nanoviricides develops new drug candidates against MERS infection

...

6 May 2014

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).

6 May 2014

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.

1 May 2014

Influenza News and Research

Latest Influenza News and Research

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Employers to implement mandatory influenza vaccination policies for health care workers

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Despite worsening economic conditions, infant health improves among poor Americans

School-based influenza vaccine programs limited by low rates of reimbursement

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Current smoking heralds worse outcomes in pneumococcal CAP

Registration now open for interactive one day workshop for GPs

Viewpoints: GOP attacks on health law; challenging assumptions about Obamacare politics; is employer mandate worth it?

Findings from 1918 Flu Pandemic research could help improve current health policies

ACP, CECity and Pfizer announce new initiative designed to increase adult immunization rates

DaVita wins 2014 Immunization Excellence Awards in "Healthcare Personnel Campaign" category

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

Researchers create universal flu vaccine

MinuteClinic walk-in medical clinics open in central Georgia

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Johns Hopkins researchers awarded NIH contract to launch new center to track influenza viruses

Nanoviricides develops new drug candidates against MERS infection

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Biotech to the rescue

Pharmaceutical Manufacturing - Industry Focus eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in